Stoddard named Schmidt Science Polymath
Wednesday, Jun 29, 2022
Schmidt Futures announced today that Mary Caswell “Cassie” Stoddard is one of 10 Schmidt Science Polymaths for 2022.
Genomics
Campbell-Staton and Kocher named Pew Scholars in the Biomedical Sciences
Wednesday, Jun 15, 2022
The Pew Charitable Trusts announced today that Princeton ecologists Shane Campbell-Staton and Sarah Kocher are members of the newest class of the Pew Scholars Program in the Biomedical Sciences, two of the 22 early-career scientists who will receive four years of funding to explore pressing questions in health and medicine.
Princeton chemists find the surprisingly simple way mammals keep their bloodstream in balance
Tuesday, Mar 1, 2022
Chemists tend to think of the human body as operating out of a sense-and-respond paradigm. For example, you eat sugar, the pancreas senses the intake, and it responds by releasing the hormone insulin to keep your glucose levels in check.
Scientists have long wondered whether there is a similar regulatory strategy for clearing other metabolites, like amino acids, to keep blood levels in a healthy range.
The short answer: Nope.
Preclinical study from Ludwig Princeton Branch shows keto diet could enhance pancreatic cancer therapy
Friday, Feb 11, 2022
A preclinical study has demonstrated that a common weight-loss diet could enhance the efficacy of chemotherapy for pancreatic cancer.
Annual Princeton innovation conference highlighted University's initiative to transform research into societal benefit
Thursday, Jan 20, 2022
Two-day program included focus on University’s commitment to grow the New Jersey innovation ecosystem
A.J. te Velthuis studies why some viruses are deadly while others are harmless
Thursday, Jan 6, 2022
Viruses outnumber humans by about 400 trillion to one, and yet pandemics are rare. Why? Why do a few viruses inflict so much damage, when the vast majority are harmless or even helpful?
Those questions drive A.J. te Velthuis, a virologist who joined Princeton’s molecular biology faculty in January 2021.
Oral and gut microbes can inactivate an antidiabetic drug, Princeton scientists find
Tuesday, Dec 21, 2021
Acarbose is a commonly prescribed antidiabetic drug that helps control blood sugar levels by inhibiting human enzymes that break down complex carbohydrates. Now, new research from the laboratory of Princeton researcher Mohamed Donia demonstrates that some bacteria in the mouth and gut can inactivate acarbose and potentially affect the clinical performance of the drug and its impact on bacterial members of the human microbiome.
New cancer therapy from Yibin Kang’s lab holds potential to switch off major cancer types without side effects
Monday, Nov 29, 2021
Imagine you could cure cancer by targeting one tiny gene. Imagine that same gene occurred in every major cancer, including breast, prostate, lung, liver and colon. Imagine that the gene is not essential for healthy activity, so you could attack it with few or no negative side effects.
Mona Singh is tailoring tools to crack the cancer code
Monday, Dec 6, 2021
Watch the new “Dare to Venture” video to see how Singh blends computer science and biology.
Three Princeton researchers win NIH high-risk, high-reward fellowships
Friday, Nov 5, 2021
Princeton faculty members Coleen Murphy, Mohamed Abou Donia and Zemer Gitai are among 20 researchers nationwide to receive 2021 Transformative Research Awards from the National Institutes of Health (NIH).
Pages
